Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26F57WN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,149
Award facts
- Contract value 100% obligated
- $33,149.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $33,149.36 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on February 4, 2026, for the supply of Wegovy 2.4 mg/0.75 mL pens with an ultimate completion date of February 5, 2026. This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the primary vehicle for pharmaceutical and medical supply deliveries to military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company competes on a full and open basis for federal contracts and maintains an extensive portfolio of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. This specific delivery order for Wegovy, a GLP-1 receptor agonist used for weight management, reflects the company's ongoing role in supplying specialized pharmaceutical products to support Department of Defense healthcare requirements.
Quick answers
Who was awarded contract SPE2DR26F57WN?
SPE2DR26F57WN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F57WN worth?
The government has obligated $33,149 on SPE2DR26F57WN.
Is contract SPE2DR26F57WN an order under another contract?
Yes. SPE2DR26F57WN is a delivery order under SPE2DR25D2006, an indefinite delivery contract.
Was contract SPE2DR26F57WN competed?
The extent of competition for SPE2DR26F57WN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award